The Joint Clinical Research Board (JCRB) is a formal part of the oversight structures of both Queen Mary and Barts Health.

The JCRB was established to oversee the work of the JRMO and provide assurance to both Barts Health and Queen Mary that its clinical research is being carried out in accordance with:

• Barts Health and Queen Mary's clinical research strategies and policies;
• Legal and regulatory requirements;
• Financial regulations; and
• The JCRB's formal Terms of Reference (revised March 2023) [PDF 141KB]

The remit of the JCRB includes all clinical research at Barts Health NHS Trust and Queen Mary's Faculty of Medicine and Dentistry, with a particular focus on research involving human subjects and tissues. It may, from time to time, set research-related activity targets and monitor progress in achieving them. In June 2022 it merged with the Barts Health Research Board, which was then disbanded.

The JCRB is accountable to the Barts Health Board and to Queen Mary's Senior Executive Team. 

Forthcoming meetings 

• 6 June 2024
• 26 September 2024
• 18 December 2024
• 13 March 2025
• 11 June 2025

Agreed minutes

• March 2024 (when agreed at the next meeting)
• December 2023 [PDF 212KB]
• September 2023 [PDF 231KB]
• June 2023 [PDF 222KB]
• March 2023 [PDF 206KB]
• November 2022 [PDF 207KB]
• September 2022 [PDF 202KB]
• June 2022 [PDF 201KB]
• February 2022 [PDF 270KB]
• October 2021 [PDF 647KB]
• June 2021 [PDF 606KB]
• March 2021 [PDF 622KB]
• December 2020 [PDF 509KB]
• July 2020 [PDF 257KB]
• March 2020 [PDF 259KB]
• December 2019 [PDF 263KB]
• June 2019 [PDF 268KB]
• December 2018 [PDF 278KB]
• September 2018 [PDF 278KB]
• June 2018 [PDF 358KB]
• March 2018 [PDF 553KB]

If you have any questions about the JCRB please contact the Board's Secretary Nick Good, Communications & Secretariat Manager in the JRMO: nicholas.good@nhs.net